[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-361267-105":59,"doc-detail-361267-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","the-predictive-role-of-tertiary-lymphoid-structures-in-the-prognosis-and-response-to-immunotherapy-of-bladder-cancer-patients-a-systematic-review-and-meta-analysis","The predictive role of tertiary lymphoid structures in the prognosis and response to immunotherapy of bladder cancer patients - a systematic review and meta-analysis","","Association between tertiary lymphoid structures (TLS) and clinical outcomes in bladder cancer (BCa), including value for predicting immunotherapy response, remains inconsistent. This systematic review and meta-analysis evaluated TLS links with survival outcomes, clinicopathological features, and immunotherapy response. Searches of PubMed, Embase, and Web of Science up to February 1, 2026 extracted hazard ratios for overall survival, progression-free survival, and disease-free survival and pooled them.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/the-predictive-role-of-tertiary-lymphoid-structures-in-the-prognosis-and-response-to-immunotherapy-of-bladder-cancer-patients-a-systematic-review-and-meta-analysis/361267/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/the-predictive-role-of-tertiary-lymphoid-structures-in-the-prognosis-and-response-to-immunotherapy-of-bladder-cancer-patients-a-systematic-review-and-meta-analysis/361267.png","ImageObject",300,407,{"name":92,"@type":93},"OmBimo","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",14,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What was the main objective of the systematic review and meta-analysis?","Question",{"text":113,"@type":114},"To evaluate how tertiary lymphoid structures (TLS) relate to survival outcomes in bladder cancer, examine associations with clinicopathological characteristics, and summarize evidence on TLS and immunotherapy response.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How were outcomes such as OS, PFS, and DFS analyzed?",{"text":118,"@type":114},"The review extracted hazard ratios with 95% confidence intervals for overall survival, progression-free survival, and disease-free survival from included studies, then pooled the results.",{"name":120,"@type":111,"acceptedAnswer":121},"What did the pooled results show about TLS and prognosis?",{"text":122,"@type":114},"Higher TLS levels were significantly associated with improved overall survival, progression-free survival, and disease-free survival in bladder cancer patients.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},361267,1790807309,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},962090893581,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Hu etal. BMC Cancer (2026) 26:999 BMC Cancer  \n[https://doi.org/10.1186/s12885-026-16326-2](https://doi.org/10.1186/s12885-026-16326-2)  \nSYSTEMATIC REVIEW Open Access  \nThe predictive role of tertiary lymphoid  structures in the prognosis and response to immunotherapy of bladder cancer patients:  \na systematic review and meta-analysis  \nPoning Hu1,2†, Chen Wang1†, Xinbo Zeng1,2†, Shengxi Jin1,2†, Jiaye Huang1,2, Qian Wang1,2, Xiaoyang Li1, Yiqing Du 1, Yuxuan Song1* and Tao Xu1*  \nAbstract  \nBackground The association between tertiary lymphoid structures (TLS) and clinical outcomes in bladder cancer (BCa) patients, particularly their value in predicting immunotherapy response, remains inconsistent and has not been systematically evaluated.  \nObjective This systematic review and meta-analysis aimed to: (1) evaluate the association between TLS and survival outcomes in BCa; (2) examine the relationship between TLS and clinicopathological characteristics; and (3) summarize evidence on TLS and immunotherapy response.  \nMethods We systematically searched PubMed, Embase, and Web of Science from inception to February 1, 2026. Hazard ratios (HRs) with 95% confidence intervals (CIs) for overall survival (OS), progression-free survival (PFS), and disease-free survival (DFS) were extracted and pooled. The study protocol was registered with PROSPERO (CRD420261282595) .  \nResults Eight studies involving 1706 patients were included in the quantitative synthesis. Pooled analysis revealed that high TLS levels were significantly associated with improved OS (HR = 0 .49, 95% CI: 0 .33–0. 74), PFS (HR = 0 . 51, 95% CI: 0 .45–0. 58), and DFS (HR = 0 .42, 95% CI: 0 .22–0. 79) . TLS showed a significant correlation only with tumor multiplicity among various clinicopathological features. Qualitative synthesis of six studies suggested that while baseline TLS had limited predictive value for immunotherapy response, therapy-induced increases in TLS number, density, and maturation were consistently associated with favorable treatment outcomes.  \n†Poning Hu, Chen Wang, Xinbo Zeng and Shengxi Jin share the first authorship.  \n*Correspondence:  \nYuxuan Song [yuxuan_song@bjmu.edu.cn](yuxuan_song@bjmu.edu.cn)[ ](yuxuan_song@bjmu.edu.cn)Tao Xu [xutao@pkuph.edu.cn](xutao@pkuph.edu.cn)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/licenses/by-nc-nd/4.0/](vecommons.org/licenses/by-nc-nd/4.0/.)[.](vecommons.org/licenses/by-nc-nd/4.0/.)  \nHu et al. BMC Cancer (2026) 26:999 Page 2 of 13  \nConclusion High TLS levels are associated with favorable survival outcomes in bladder cancer patients, supporting their role as a prognostic biomarker. Therapy-induced TLS dynamics, rather than baseline status alone, may be a more relevant predictive biomarker for immunotherapy efficacy. These findings warrant validation in larger, prospective studies.  \nKeywords Tertiary lymphoid structures (TLS), Urothelial carcinoma (UC), Immunothe","cbCaic9pVnOUrfOv","https://ap.wps.com/l/cbCaic9pVnOUrfOv","pdf",2239637,13,"English","# Abstract\n## Background\n## Objective\n## Methods\n## Results\n## Conclusion\n## Keywords\n# Introduction","[{\"question\":\"What was the main objective of the systematic review and meta-analysis?\",\"answer\":\"To evaluate how tertiary lymphoid structures (TLS) relate to survival outcomes in bladder cancer, examine associations with clinicopathological characteristics, and summarize evidence on TLS and immunotherapy response.\"},{\"question\":\"How were outcomes such as OS, PFS, and DFS analyzed?\",\"answer\":\"The review extracted hazard ratios with 95% confidence intervals for overall survival, progression-free survival, and disease-free survival from included studies, then pooled the results.\"},{\"question\":\"What did the pooled results show about TLS and prognosis?\",\"answer\":\"Higher TLS levels were significantly associated with improved overall survival, progression-free survival, and disease-free survival in bladder cancer patients.\"}]","The predictive role of tertiary lymphoid structures in the prognosis and response to immunotherapy of bladder cancer patients - a systematic review and meta-analysis | PDF",1790143756,33,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4fd84a82e5c4d53720dbc556a6254e72.webp",983,1310,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7fa4f625c4d05dbc179c586767473bc8.webp",982,1309,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0d3d08b7e4786dc805b709dd007d788b.webp",981,1308,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bf39d00570595ef32c8688011a18306d.webp",980,1306]